Eurosurveillance remains in the updated list of the Directory of Open Access Journals (DOAJ). It was first added to the DOAJ on 9 September 2004. Eurosurveillance is also listed in the Securing a Hybrid Environment for Research Preservation and Access / Rights MEtadata for Open archiving (SHERPA/RoMEO) [2], a database which uses a colour‐coding scheme to classify publishers according to their self‐archiving policy and to show the copyright and open access self-archiving policies of academic journals. Eurosurveillance is listed there as a ‘green’ journal, which means that authors can archive pre-print (i.e. pre-refereeing), post-print (i.e. final draft post-refereeing) and archive the publisher's version/PDF.

ESCAIDE participants are invited to the fifth Eurosurveillance scientific seminar on 30 November 2016

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Read our articles on Zika virus infection

Read our articles on mcr-1-mediated colistin resistance

Note of concern published for 'Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015',

In this issue

Home Eurosurveillance Weekly Release  2003: Volume 7/ Issue 36 Article 2
Back to Table of Contents

Eurosurveillance, Volume 7, Issue 36, 04 September 2003

Citation style for this article: Joseph C, Beyrer K. Legionnaires’ disease associated with a cruise liner – Germany: update. Euro Surveill. 2003;7(36):pii=2286. Available online:

Legionnaires’ disease associated with a cruise liner – Germany: update

Carol Joseph (, European Surveillance Scheme for travel associated legionnaires' disease project coordinator (, Health Protection Agency Communicable Disease Surveillance Centre, London, England, and Konrad Beyrer, State Health Authority of Lower Saxony, Germany.

The number of cases of legionnaires’ disease in passengers who traveled on the Ocean Monarch cruise ship from 6-23 August is still three (1). One case has been confirmed by culture of the organism and the others by urinary antigen detection.

The ship remained berthed at Harwich (England) for one week where it underwent extensive environmental investigations and implementation of control measures. Hot and cold water samples were taken for analysis and have yielded isolates of Legionella pneumophila serogroups 1 and 2-14. These isolates as well as those of the German case will be sent to the reference laboratory at the University of Dresden for further investigation. The ship left for Dover (England) on 30 August after all the control measures had been reviewed by marine and port health staff, and staff from England and Wales’ Health Protection Agency. Further water sampling was carried out in Dover before the ship sailed on its next cruise the following day.

In Germany, passengers associated with the cruise outbreak are being followed up to assist with identification of the source of infection and to assess the full extent of associated illness. Further information about the cluster can be obtained from the State Health Authority of Lower Saxony, Germany at the following address by contacting Adolf Windorfer via email (, telephone (+49 (0) 511 4505 500), or fax (+49 (0) 511 4505 502).

  1. Joseph C. Legionnaires' disease associated with a cruise liner – Germany. Eurosurveillance Weekly 2003; 7 (35): 28/08/2003. (

back to top

Back to Table of Contents

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN 1560-7917] - ©2007-2016. All rights reserved.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.